Published in Br J Pharmacol on February 01, 1991
Effect of niflumic acid on noradrenaline-induced contractions of the rat aorta. Br J Pharmacol (1996) 1.18
Differential effects of acetylcholine, nitric oxide and levcromakalim on smooth muscle membrane potential and tone in the rabbit basilar artery. Br J Pharmacol (1993) 1.14
Effects of cromakalim on the electrical slow wave in the circular muscle of guinea-pig gastric antrum. Br J Pharmacol (1993) 0.96
Comparative effects of BRL 38227, nitrendipine and isoprenaline on carbachol- and histamine-stimulated phosphoinositide metabolism in airway smooth muscle. Br J Pharmacol (1992) 0.94
The contribution of Rb-permeable potassium channels to the relaxant and membrane hyperpolarizing actions of cromakalim, RP49356 and diazoxide in bovine tracheal smooth muscle. Br J Pharmacol (1991) 0.94
Pharmacology of the potassium channel openers. Cardiovasc Drugs Ther (1995) 0.93
Direct action of BRL 38227 and glibenclamide on intracellular calcium stores in cultured airway smooth muscle of rabbit. Br J Pharmacol (1992) 0.89
Lack of effect of potassium channel openers on ATP-modulated potassium channels recorded from rat ventromedial hypothalamic neurones. Br J Pharmacol (1992) 0.89
Evidence that depletion of internal calcium stores sensitive to noradrenaline elicits a contractile response dependent on extracellular calcium in rat aorta. Br J Pharmacol (1993) 0.88
Effects of the novel potassium channel opener, UR-8225, on contractile responses in rat isolated smooth muscle. Br J Pharmacol (1993) 0.85
Effects of cromakalim on the contraction and the membrane potential of the circular smooth muscle of guinea-pig stomach. Br J Pharmacol (1992) 0.84
Effects of rubidium on responses to potassium channel openers in rat isolated aorta. Br J Pharmacol (1993) 0.84
Hyperpolarization induced by K+ channel openers inhibits Ca2+ influx and Ca2+ release in coronary artery. Cardiovasc Drugs Ther (1993) 0.80
Effect of K+ channel-modulating drugs on the vasoconstrictor responses of leukotrienes C4, D4 and angiotensin II in the guinea-pig isolated perfused heart. Br J Pharmacol (1992) 0.76
Interactions between indomethacin, noradrenaline and vasodilators in the fetal rabbit ductus arteriosus. Br J Pharmacol (1994) 0.76
Monophasic action potentials and Ca(2+) transients in ischaemically preconditioned rabbit ventricular muscle. Neth Heart J (2003) 0.75
Characteristics of the contractile response of rabbit aorta produced by cromakalim in calcium-free solution. Br J Pharmacol (1992) 0.75
Hyperpolarizing vasodilators activate ATP-sensitive K+ channels in arterial smooth muscle. Science (1989) 5.60
Two kinds of calcium channels in canine atrial cells. Differences in kinetics, selectivity, and pharmacology. J Gen Physiol (1985) 5.16
Comparison of the effects of BRL 34915 and verapamil on electrical and mechanical activity in rat portal vein. Br J Pharmacol (1986) 4.75
Excitation-contraction coupling in rabbit aorta studied by the lanthanum method for measuring cellular calcium influx. Circ Res (1972) 4.27
The effects of BRL 34915 and nicorandil on electrical and mechanical activity and on 86Rb efflux in rat blood vessels. Br J Pharmacol (1986) 3.68
Sarcoplasmic reticulum and excitation-contraction coupling in mammalian smooth muscles. J Cell Biol (1972) 3.28
Electrical and mechanical effects of BRL34915 in guinea-pig isolated trachealis. Br J Pharmacol (1986) 3.07
Effect of apamin on responses to BRL 34915, nicorandil and other relaxants in the guinea-pig taenia caeci. Br J Pharmacol (1986) 2.89
The receptor for antidiabetic sulfonylureas controls the activity of the ATP-modulated K+ channel in insulin-secreting cells. J Biol Chem (1987) 2.24
Glyburide blocks the relaxation response to BRL 34915 (cromakalim), minoxidil sulfate and diazoxide in vascular smooth muscle. J Pharmacol Exp Ther (1989) 1.82
Effect of the K+ efflux stimulating vasodilator BRL 34915 on 86Rb+ efflux and spontaneous activity in guinea-pig portal vein. Br J Pharmacol (1987) 1.81
BRL 34915, a novel antihypertensive agent: comparison of effects on blood pressure and other haemodynamic parameters with those of nifedipine in animal models. J Cardiovasc Pharmacol (1986) 1.79
Inositol trisphosphate modification of ion transport in rough endoplasmic reticulum. Proc Natl Acad Sci U S A (1985) 1.77
Ca2+-movements in muscle modulated by the state of K+-channels in the sarcoplasmic reticulum membranes. Pflugers Arch (1987) 1.56
The relaxant action of BRL 34915 in rat uterus. Br J Pharmacol (1987) 1.45
Specificity of action of the novel antihypertensive agent, BRL 34915, as a potassium channel activator. Comparison with nicorandil. Biochem Pharmacol (1987) 1.34
Cromakalim, nicorandil and pinacidil: novel drugs which open potassium channels in smooth muscle. Gen Pharmacol (1989) 1.31
Anti-vasoconstrictor effects of the K+ channel opener cromakalim on the rabbit aorta--comparison with the calcium antagonist isradipine. Br J Pharmacol (1988) 1.27
The action of diazoxide and minoxidil sulphate on rat blood vessels: a comparison with cromakalim. Br J Pharmacol (1990) 1.26
Mechanism of action of minoxidil sulfate-induced vasodilation: a role for increased K+ permeability. J Pharmacol Exp Ther (1988) 1.25
Differential calcium dependence of contractile responses and 86Rb efflux from the rabbit aorta induced by vasoactive stimuli. J Cell Physiol (1983) 1.16
The potassium channel opening action of pinacidil; studies using biochemical, ion flux and microelectrode techniques. Naunyn Schmiedebergs Arch Pharmacol (1988) 1.15
Relaxing actions of procaterol, a beta 2-adrenoceptor stimulant, on smooth muscle cells of the dog trachea. Br J Pharmacol (1988) 1.11
Comparison of the effluxes of 42K+ and 86Rb+ elicited by cromakalim (BRL 34915) in tonic and phasic vascular tissue. Naunyn Schmiedebergs Arch Pharmacol (1988) 1.11
Potassium-channel blockers inhibit inositol trisphosphate-induced calcium release in the microsomal fractions isolated from the rat brain. Biochem J (1988) 1.08
Correlation between phosphatidylinositol labeling and contraction in rabbit aorta: effect of alpha-1 adrenergic activation. J Pharmacol Exp Ther (1982) 0.95
Dissociation of actions of BRL 34915 in the rat portal vein. Eur J Pharmacol (1987) 0.95
Theoretical bases for vascular selectivity of Ca2+ antagonists. J Cardiovasc Pharmacol (1984) 0.90
Rabbit aorta: electrical properties and agonist-induced depolarization. Eur J Pharmacol (1989) 0.88
K+ is an endothelium-derived hyperpolarizing factor in rat arteries. Nature (1998) 6.29
The alcohol dependence syndrome: a concept as stimulus to enquiry. Br J Addict (1986) 5.32
London's skid row. Lancet (1966) 5.09
Alcohol dependence: provisional description of a clinical syndrome. Br Med J (1976) 4.96
Comparison of the effects of BRL 34915 and verapamil on electrical and mechanical activity in rat portal vein. Br J Pharmacol (1986) 4.75
Science and the drinks industry: cause for concern. Addiction (1996) 4.63
Sensible drinking. BMJ (1996) 4.38
Alcoholism: a controlled trial of "treatment" and "advice". J Stud Alcohol (1977) 4.14
ILSI Europe, the drinks industry, and a conflict of interest undeclared. Addiction (2001) 3.76
Systematic review of the long-term effects and economic consequences of treatments for obesity and implications for health improvement. Health Technol Assess (2004) 3.73
The effects of BRL 34915 and nicorandil on electrical and mechanical activity and on 86Rb efflux in rat blood vessels. Br J Pharmacol (1986) 3.68
Acetylcholine releases endothelium-derived hyperpolarizing factor and EDRF from rat blood vessels. Br J Pharmacol (1988) 3.66
A controlled trial of inpatient and outpatient treatment of alcohol dependency. Lancet (1967) 3.41
4-1BB costimulatory signals preferentially induce CD8+ T cell proliferation and lead to the amplification in vivo of cytotoxic T cell responses. J Exp Med (1997) 3.31
Glucose intolerance but normal satiety in mice with a null mutation in the glucagon-like peptide 1 receptor gene. Nat Med (1996) 2.94
Effect of apamin on responses to BRL 34915, nicorandil and other relaxants in the guinea-pig taenia caeci. Br J Pharmacol (1986) 2.89
Specialist versus general practitioner treatment of problem drinkers. Lancet (1990) 2.88
Evidence that the spasmogenic action of tetraethylammonium in guinea-pig trachealis is both direct and dependent on the cellular influx of calcium ion. Br J Pharmacol (1983) 2.84
Endothelium-derived hyperpolarizing factor: a new endogenous inhibitor from the vascular endothelium. Trends Pharmacol Sci (1988) 2.79
The pharmacology of ATP-sensitive potassium channels. Annu Rev Pharmacol Toxicol (1993) 2.64
Some effects of sodium nitroprusside, methoxyverapamil (D600) and nifedipine on rat portal vein. Br J Pharmacol (1980) 2.52
The impact of maternal BMI status on pregnancy outcomes with immediate short-term obstetric resource implications: a meta-analysis. Obes Rev (2008) 2.39
Simultaneous long-term recording of the mechanical and intracellular electrical activity of smooth muscles. J Pharmacol Methods (1980) 2.37
Deaths of drug addicts in the United Kingdom 1967-81. Br Med J (Clin Res Ed) (1985) 2.35
Contemporary themes: relevance of american experience of narcotic addiction to the british scene. Br Med J (1967) 2.29
Executive functioning, temporal discounting, and sense of time in adolescents with attention deficit hyperactivity disorder (ADHD) and oppositional defiant disorder (ODD). J Abnorm Child Psychol (2001) 2.27
The British approach to the treatment of heroin addiction. Lancet (1969) 2.26
Drugs, drug dependence and the concept of plasticity. Q J Stud Alcohol (1974) 2.17
Long-term non-pharmacologic weight loss interventions for adults with type 2 diabetes. Cochrane Database Syst Rev (2005) 2.17
The development of a questionnaire to measure severity of alcohol dependence. Br J Addict Alcohol Other Drugs (1979) 2.16
Abuse of methylamphetamine. Br Med J (1969) 2.15
Rapid detection, differentiation and typing of methicillin-resistant Staphylococcus aureus harbouring either mecA or the new mecA homologue mecA(LGA251). Clin Microbiol Infect (2012) 2.08
Effect of disinfectants on pathogenic free-living amoebae: in axenic conditions. Appl Environ Microbiol (1980) 2.08
An investigation of persistent microfilaridermias despite multiple treatments with ivermectin, in two onchocerciasis-endemic foci in Ghana. Ann Trop Med Parasitol (2004) 2.05
Addiction treatment and the making of large claims. Addiction (2000) 2.05
Frequency of severe neutropenia associated with amodiaquine prophylaxis against malaria. Lancet (1986) 2.04
Two novel IL-1 family members, IL-1 delta and IL-1 epsilon, function as an antagonist and agonist of NF-kappa B activation through the orphan IL-1 receptor-related protein 2. J Immunol (2001) 2.03
Shakespeare and the meaning of authorship. Addiction (2000) 2.02
Pharmacokinetics of halofantrine in man: effects of food and dose size. Br J Clin Pharmacol (1989) 1.97
Cocaine and crack. BMJ (1989) 1.96
Characterization of an apamin-sensitive small-conductance Ca(2+)-activated K(+) channel in porcine coronary artery endothelium: relevance to EDHF. Br J Pharmacol (2002) 1.94
DNA damage in human sperm is related to urinary levels of phthalate monoester and oxidative metabolites. Hum Reprod (2006) 1.94
Rapid diagnosis of bacteremia by universal amplification of 23S ribosomal DNA followed by hybridization to an oligonucleotide array. J Clin Microbiol (2000) 1.88
Corticotropin-releasing factor, but not corticosterone, is involved in stress-induced relapse to heroin-seeking in rats. J Neurosci (1997) 1.84
Pharmacokinetics of primaquine in man: identification of the carboxylic acid derivative as a major plasma metabolite. Br J Clin Pharmacol (1984) 1.82
Intracellular calcium concentration during low-frequency fatigue in isolated single fibers of mouse skeletal muscle. J Appl Physiol (1985) (1993) 1.79
Use of cell cultures as an indicator of pathogenicity of free-living amoebae. J Clin Pathol (1978) 1.72
Thirty-month follow-up of sub-optimal responders to multiple treatments with ivermectin, in two onchocerciasis-endemic foci in Ghana. Ann Trop Med Parasitol (2004) 1.67
Relevance and utility of courses in medical ethics. A survey of physicians' perceptions. JAMA (1985) 1.67
Census of a reception centre. Br J Psychiatry (1968) 1.64
Protein domains governing interactions between E2F, the retinoblastoma gene product, and human papillomavirus type 16 E7 protein. Mol Cell Biol (1993) 1.64
Androgen-dependent cell cycle arrest and apoptotic death in PC-3 prostatic cell cultures expressing a full-length human androgen receptor. Mol Cell Endocrinol (1997) 1.62
Ion channel modulation by NS 1619, the putative BKCa channel opener, in vascular smooth muscle. Br J Pharmacol (1994) 1.60
Orthodontic auxiliaries--a pilot project. Br Dent J (1998) 1.59
Psychological stress and the passage of a standard meal through the stomach and small intestine in man. Gut (1983) 1.57
Further investigation of endothelium-derived hyperpolarizing factor (EDHF) in rat hepatic artery: studies using 1-EBIO and ouabain. Br J Pharmacol (1999) 1.55
Long latency pneumonia: a case of melioidosis. J Infect (1990) 1.54
KATP--fact or artefact? New thoughts on the mode of action of the potassium channel openers. Cardiovasc Res (1994) 1.54
Transcription factor E2F binds DNA as a heterodimer. Proc Natl Acad Sci U S A (1993) 1.53
Role of gap junctions in the responses to EDHF in rat and guinea-pig small arteries. Br J Pharmacol (1999) 1.53
Endothelium-dependent effects of acetylcholine in rat aorta: a comparison with sodium nitroprusside and cromakalim. Br J Pharmacol (1988) 1.51
Characterization of potassium currents modulated by BRL 38227 in rat portal vein. Br J Pharmacol (1992) 1.50
Antimicrobial drug resistance in isolates of Salmonella enterica from cases of salmonellosis in humans in Europe in 2000: results of international multi-centre surveillance. Euro Surveill (2003) 1.50
The disposition of amodiaquine in man after oral administration. Br J Clin Pharmacol (1987) 1.49
Nomenclature and classification of drug- and alcohol-related problems: a WHO Memorandum. Bull World Health Organ (1981) 1.46
The relaxant action of BRL 34915 in rat uterus. Br J Pharmacol (1987) 1.45
The alcoholic doctor. A case of neglect. Lancet (1975) 1.45
Molecular analysis of isoniazid-resistant Mycobacterium tuberculosis isolates from England and Wales reveals the phylogenetic significance of the ahpC -46A polymorphism. Antimicrob Agents Chemother (2005) 1.45
Androgen-induced inhibition of cell proliferation in an androgen-insensitive prostate cancer cell line (PC-3) transfected with a human androgen receptor complementary DNA. Cancer Res (1993) 1.44
Evidence that the mechanism of the inhibitory action of pinacidil in rat and guinea-pig smooth muscle differs from that of glyceryl trinitrate. Br J Pharmacol (1987) 1.41
Cost-effectiveness of cell salvage and alternative methods of minimising perioperative allogeneic blood transfusion: a systematic review and economic model. Health Technol Assess (2006) 1.41
Hypnosis and desinsitization for Phobias: a controlled prospective trial. Br J Psychiatry (1968) 1.40
Abstinence or control: the outcome for excessive drinkers two years after consultation. Behav Res Ther (1976) 1.40
Recombinant oncostatin M stimulates the production of acute phase proteins in HepG2 cells and rat primary hepatocytes in vitro. J Immunol (1992) 1.40
Effects of methyl beta-cyclodextrin on EDHF responses in pig and rat arteries; association between SK(Ca) channels and caveolin-rich domains. Br J Pharmacol (2007) 1.39
Who was Jellinek? Br J Psychiatry (1991) 1.39
A paper which must be withdrawn from publication. Addiction (2001) 1.38
A comparison of several calcium antagonists on uterine, vascular and cardiac muscles from the rat. Br J Pharmacol (1985) 1.38
Endothelium-derived hyperpolarizing factor--a critical appraisal. Prog Drug Res (1998) 1.35
The disposition of amodiaquine in Zambians and Nigerians with malaria. Br J Clin Pharmacol (1990) 1.34
Levcromakalim may induce a voltage-independent K-current in rat portal veins by modifying the gating properties of the delayed rectifier. Br J Pharmacol (1993) 1.33
Some features of the spasmogenic actions of acetylcholine and histamine in guinea-pig isolated trachealis. Br J Pharmacol (1984) 1.33
Immunity to pathogenic free-living amoebae: role of humoral antibody. Infect Immun (1980) 1.31
Cromakalim, nicorandil and pinacidil: novel drugs which open potassium channels in smooth muscle. Gen Pharmacol (1989) 1.31
The spasmogenic action of potassium chloride in guinea-pig trachealis. Br J Pharmacol (1983) 1.31
Drinking problems: putting the Third World on the map. Lancet (1979) 1.30
Determination of primaquine in biological fluids by reversed-phase high-performance liquid chromatography. J Chromatogr (1984) 1.30
Actions of cromakalim on ionic currents recorded from single smooth muscle cells of the rat portal vein. J Pharmacol Exp Ther (1990) 1.30
Characteristics of cromakalim-induced relaxations in the smooth muscle cells of guinea-pig mesenteric artery and vein. Br J Pharmacol (1988) 1.30
Cardiovascular toxicity and distribution kinetics of intravenous chloroquine. Br J Clin Pharmacol (1986) 1.30
Role of gap junctions and EETs in endothelium-dependent hyperpolarization of porcine coronary artery. Br J Pharmacol (2000) 1.30
Virulence of pathogenic free-living amebae. J Parasitol (1978) 1.29
Functional evidence of a role for two-pore domain potassium channels in rat mesenteric and pulmonary arteries. Br J Pharmacol (2004) 1.29
Monitoring changing patterns of drug dependence in accident and emergency departments. Drug Alcohol Depend (1987) 1.29
Structure-activity relationships of K+ channel openers. Trends Pharmacol Sci (1990) 1.28